Recent News

• 05.09.2025 - Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
• 05.09.2025 - Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
• 05.09.2025 - Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
• 05.08.2025 - Exagen Inc. Prices Public Offering of Common Stock
• 05.08.2025 - Exagen Inc. Prices Public Offering of Common Stock
• 05.08.2025 - Exagen Inc. Prices Public Offering of Common Stock
• 05.07.2025 - Exagen Inc. Announces Proposed Public Offering of Common Stock
• 05.07.2025 - Exagen Inc. Announces Proposed Public Offering of Common Stock
• 05.07.2025 - Exagen Inc. Announces Proposed Public Offering of Common Stock
• 05.05.2025 - Q1 2025 Earnings Call

Recent Filings

• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 05.08.2025 - 8-K Current report
• 05.07.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 05.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.05.2025 - EX-99.1 EX-99.1